Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Mycota Powder
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Zinc undecylenate, Undecylenic acid may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
Possible side effects
May cause skin irritation (redness and itching) or allergic reactions. If you have any side effects, stop use and tell your doctor or pharmacist. Reporting of side effects lf you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.
Storing the medicine Keep out of the sight and reach of children. Use by the date shown on the bottom of the pack. Active ingredients: zinc undecylenate 20% w/w, undecylenic acid 2% w/w. Also contains: maize starch, light kaolin and perfume. Text revised in July 2020 Manufactured by Laboratoria Smeets NV. Fotografielaan 42, B-2610 Antwerpen – Wilrijk. Licence holder Thornton and Ross Ltd., Huddersfield, HD7 5QH, UK. PL 00240/0061 92797202007 V-SB0012/D
X Do not use the medicine if you have…. ¢ An allergy to any of the ingredients listed.
! Pregnant or breastfeeding
POW OD E R (Zinc Undecylenate, Undecylenic Acid) TREATS
AND
PREVENTS
ATHLETE'S FOOT
Ask your doctor or pharmacist for advice before use if you are pregnant, might be pregnant or are breastfeeding.
! Important information about some of the ingredients This medicine contains fragrance with Euganol, which may cause an allergic reaction.
/ How to use the medicine Apply to the skin. ¢ Do not use on broken skin. ¢ Keep away from eyes and other sensitive areas. Stop treatment if irritation is severe. Adults, the elderly and children: Treatment of Athlete's Foot ¢ Wash and dry the foot thoroughly each morning and night. ¢ Sprinkle the powder onto the affected area. ¢ Take care to make sure plenty of powder is applied between the toes. ¢ Wear clean socks or stockings each day dusted inside with the powder. ¢ Continue this treatment for one week after all signs of infection have disappeared. 70 g e
Frequently asked questions about Mycota Powder
How do I take Mycota Powder?
Mycota Powder comes as powder. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
What is the active substance in Mycota Powder?
The active substance in Mycota Powder is zinc undecylenate, undecylenic acid.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Mycota Powder, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Mycota Powder without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: zinc undecylenate, undecylenic acid
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
For the treatment and prevention of athlete's foot.
4.2. Posology and method of administration
Route of administration: Cutaneous
Treatment
Each night and morning wash and thoroughly dry the affected parts and sprinkle on Mycota Powder (preferably after applying Mycota Cream or Spray to the area). Ensure a generous application between the toes and each day wear clean socks or stockings dusted inside with Mycota Powder. Continue treatment for one week after all evidence of infection has disappeared.
Prevention
Sprinkle Mycota Powder inside socks or stockings daily.
4.3. Contraindications
Hypersensitivity to any of the ingredients.
4.4. Special warnings and precautions for use
For external use only.
Contact with the eyes and mucous membranes should be avoided.
Do not apply to broken skin.
Treatment should be discontinued if irritation is severe.
Keep all medicines out of the reach of children.
Excipient warnings:
This medicine contains fragrance with Euganol, which may cause an allergic reaction.
4.5. Interaction with other medicinal products and other forms of interaction
No clinically significant interactions known.
4.6. Pregnancy and lactation
The safety of Mycota Powder during pregnancy and lactation has not been established but use during these periods is not considered to constitute a hazard.
4.7. Effects on ability to drive and use machines
No or negligible influence.
4.8. Undesirable effects
Hypersensitivity reactions may occur occasionally. Irritation of the skin may rarely occur.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
4.9. Overdose
Excessive application to the skin is unlikely to cause untoward effects. In the unlikely event of ingestion of Mycota Powder symptoms of overdose may include nausea, vomiting and general intestinal disturbances.
Treatment
Symptomatic.
🇵🇱 Known in Poland as
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
- ProursanAcidum undecylenicum 250 mg
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
💬 Ask about this leaflet
Ask anything about Mycota Powder. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.